Biotech Startups
10,020 companies tagged Biotech, with their investors and founders.
HealthΕme combines insurance with health navigation services to improve how patients access, finance, and receive precision healthcare.
0 investors
0 investors
0 investors
0 investors
0 investors
Helicase Venture is a life sciences investment firm focused on biotech and healthcare innovation. The firm invests in and supports the development of pharmaceutical and biotechnology companies.
0 investors
0 investors
Heligenics is a genomics and cell biology company that develops assays and platforms for drug screening and genetic analysis. The company serves pharmaceutical and biotech organizations conducting research in functional genomics and cellular engineering.
0 investors
0 investors
Helix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.
0 investors
0 investors
Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.
0 investors
Hemanext develops oxygen-controlled storage technology to preserve red blood cell quality and function during transfusion storage. The company serves hospitals and blood establishments seeking to improve patient outcomes in transfusion medicine.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Hepanova is a clinical-stage biotech developing first-in-class oral small-molecule therapeutics for chronic liver diseases and inflammatory conditions, including MASH, liver fibrosis, and IBD. Its lead candidate, HPN-01, is an oral dual IKKΞ±/IKKΞ² inhibitor that has completed a U.S. Phase 1 trial.
0 investors
Hepion Pharma is a pharmaceutical company with a therapeutic focus on hepatocellular carcinoma (liver cancer). This page is an investor presentations section with no substantive content available.
0 investors
0 investors
0 investors
Hexamer Therapeutics develops a modular, room-temperature, peptide-based vaccine platform for therapeutic cancer and infectious disease vaccines, aiming to move quickly from disease target to active vaccine. It also licenses the platform to companies developing vaccines for animals such as swine, cattle, sheep, horses and companion animals.
0 investors
0 investors